BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Revenue

BF Biosciences had revenue of 2.78B PKR in the quarter ending September 30, 2026, with 14.46% growth. This brings the company's total for the last twelve months to 9.81B, up 42.56% year-over-year. In the fiscal year ending June 30, 2026, BF Biosciences had annual revenue of 9.46B with 62.08% growth. That makes BF Biosciences the 30,311th largest company in the world by revenue and 213th in Pakistan.

• Revenue (ttm): 9.81B
• Revenue Growth: +42.56%
• P/S Ratio: 1.18
• Revenue / Employee: 11.52M
• Employees: 852
• Market Cap: 11.56B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Pakistan 9.31B 98.4%
• Nepal 40.69M 0.4%
• Cambodia 26.91M 0.3%
• Kenya 18.65M 0.2%
• Uzbekistan 17.30M 0.2%
• Mauritania 11.37M 0.1%
• Afghanistan 11.03M 0.1%
• Other 21.57M 0.2%

Fiscal year ended Jun 30, 2026 See the full BF Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	9.46B	3.62B	62.08%
Jun 30, 2025	5.84B	2.18B	59.55%
Jun 30, 2024	3.66B	1.85B	102.19%
Jun 30, 2023	1.81B	288.82M	18.99%
Jun 30, 2022	1.52B	-234.10M	-13.34%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error